{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T21:01:43Z","timestamp":1782421303330,"version":"3.54.5"},"reference-count":39,"publisher":"Japan Society for Clinical Immunology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. J. Clin. Immunol.","Jpn.J.clin.Immun"],"published-print":{"date-parts":[[2014]]},"DOI":"10.2177\/jsci.37.154","type":"journal-article","created":{"date-parts":[[2014,6,29]],"date-time":"2014-06-29T23:59:17Z","timestamp":1404086357000},"page":"154-159","source":"Crossref","is-referenced-by-count":3,"title":["&lt;i&gt;Peptidylarginine deiminase type4&lt;\/i&gt; (&lt;i&gt;PADI4&lt;\/i&gt;) role in immune system","\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306e\u75be\u60a3\u611f\u53d7\u6027\u907a\u4f1d\u5b50\u3067\u3042\u308b&lt;i&gt;Peptidylarginine deiminase type 4&lt;\/i&gt;\uff08&lt;i&gt;PADI4&lt;\/i&gt;\uff09\u306e\u514d\u75ab\u7cfb\u306b\u304a\u3051\u308b\u5f79\u5272"],"prefix":"10.2177","volume":"37","author":[{"given":"Yu","family":"SERI","sequence":"first","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduation School of Medicine, University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"SHODA","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduation School of Medicine, University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"MATSUMOTO","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, University of Tsukuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"SUMIDA","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, University of Tsukuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"FUJIO","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduation School of Medicine, University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"YAMAMOTO","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduation School of Medicine, University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"972","reference":[{"key":"1","unstructured":"1) Isaacs, J.D.: The changing face of rheumatoid arthritis: sustained remission for all? <i>Nat Rev Immunol<\/i>. <b>10<\/b>: 605-611, 2010."},{"key":"2","unstructured":"2) Okada, Y., et al.: Genetics of rheumatoid arthritis contributes to biology and drug discovery. <i>Nature<\/i>. <b>506<\/b>: 376-381, 2014."},{"key":"3","unstructured":"3) Stahl, E.A., et al.: Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. <i>Nat Genet<\/i>. <b>44<\/b>: 483-489, 2012."},{"key":"4","unstructured":"4) Suzuki, A., et al.: Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. <i>Nat Genet<\/i>. <b>34<\/b>: 395-402, 2003."},{"key":"5","unstructured":"5) Ikari, K., et al.: Association between PADI4 and rheumatoid arthritis: a replication study. <i>Arthritis Rheum<\/i>. <b>52<\/b>: 3054-3057, 2005."},{"key":"6","unstructured":"6) Kang, C.P., et al.: A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. <i>Arthritis Rheumatol<\/i>. <b>54<\/b>: 90-96, 2006."},{"key":"7","unstructured":"7) Barton, A., et al.: A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. <i>Arthritis Rheum<\/i>. <b>50<\/b>: 1117-1121, 2004."},{"key":"8","unstructured":"8) Burr, M.L., et al.: PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population. <i>Ann Rheum Dis<\/i>. <b>69<\/b>: 666-670, 2010."},{"key":"9","unstructured":"9) Kochi, Y., et al.: Ethnogenetic heterogeneity of rheumatoid arthritis-implications for pathogenesis. <i>Nat Rev Rheumatol<\/i>. <b>6<\/b>: 290-295, 2010."},{"key":"10","unstructured":"10) Eyre, S., et al.: High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. <i>Nat Genet<\/i>. <b>44<\/b>: 1336-1340, 2012."},{"key":"11","unstructured":"11) Vossenaar, E.R., et al.: PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. <i>Bioessays<\/i>. <b>25<\/b>: 1106-1118, 2003."},{"key":"12","unstructured":"12) Scally, S.W., et al.: A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. <i>J Exp Med<\/i>. <b>210<\/b>: 2569-2582, 2013."},{"key":"13","unstructured":"13) Foulquier, C., et al.: Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. <i>Arthritis Rheum<\/i>. <b>56<\/b>: 3541-3553, 2007."},{"key":"14","unstructured":"14) Nakayama-Hamada, M., et al.: Comparison of enzymatic properties between hPADI2 and hPADI4. <i>Biochem Biophys Res Commun<\/i>. <b>327<\/b>: 192-200, 2005."},{"key":"15","unstructured":"15) Nakashima, K., et al.: Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes. <i>J Biol Chem<\/i>. <b>277<\/b>: 49562-49568, 2002."},{"key":"16","unstructured":"16) Arita, K., et al.: Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4. <i>Proc Natl Acad Sci U S A<\/i>. <b>103<\/b>: 5291-5296, 2006."},{"key":"17","unstructured":"17) Klareskog, L., et al.: Immunity to citrullinated proteins in rheumatoid arthritis. <i>Annu Rev Immunol<\/i>. <b>26<\/b>: 651-675, 2008."},{"key":"18","unstructured":"18) Bang, S.Y., et al.: Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study. <i>Arthritis Res Ther<\/i>. <b>12<\/b>: R115, 2010."},{"key":"19","unstructured":"19) Suzuki, T., et al.: PADI4 and HLA-DRB1 are genetic risks for radiographic progression in RA patients, independent of ACPA status: results from the IORRA cohort study. <i>PLoS One<\/i>. <b>8<\/b>: e61045, 2013."},{"key":"20","unstructured":"20) Shelef, M.A., et al.: Peptidylarginine deiminase 4 contributes to tumor necrosis factor alpha induced inflammatory arthritis. <i>Arthritis Rheumatol<\/i>. <b>66<\/b>: 1482-1491, 2014."},{"key":"21","unstructured":"21) Khandpur, R., et al.: NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. <i>Sci Transl Med<\/i>. <b>5<\/b>: 178ra40, 2013."},{"key":"22","unstructured":"22) Pratesi, F., et al.: Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps. <i>Ann Rheum Dis<\/i>. <b>73<\/b>: 1414-1422, 2013."},{"key":"23","unstructured":"23) Romero, V., et al.: Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis. <i>Sci Transl Med<\/i>. <b>5<\/b>: 209ra150, 2013."},{"key":"24","unstructured":"24) Cuthbert, G.L., et al.: Histone deimination antagonizes arginine methylation. <i>Cell<\/i>. <b>118<\/b>: 545-553, 2004."},{"key":"25","unstructured":"25) Wang, Y., et al.: Human PAD4 regulates histone arginine methylation levels via demethylimination. <i>Science<\/i>. <b>306<\/b>: 279-283, 2004."},{"key":"26","unstructured":"26) Zhang, X., et al.: Genome-wide analysis reveals PADI4 cooperates with Elk-1 to activate c-Fos expression in breast cancer cells. <i>PLoS Genet<\/i>. <b>7<\/b>: e1002112, 2011."},{"key":"27","unstructured":"27) Chang, X., Han, J.: Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors. <i>Mol Carcinog<\/i>. <b>45<\/b>: 183-196, 2006."},{"key":"28","unstructured":"28) Cui, X., et al.: The induction of microRNA-16 in colon cancer cells by protein arginine deiminase inhibition causes a p53-dependent cell cycle arrest. <i>PLoS One<\/i>. <b>8<\/b>: e53791, 2013."},{"key":"29","unstructured":"29) Guo, Q., Fast, W.: Citrullination of inhibitor of growth 4 (ING4) by peptidylarginine deminase 4 (PAD4) disrupts the interaction between ING4 and p53. <i>J Biol Chem<\/i>. <b>286<\/b>: 17069-17078, 2011."},{"key":"30","unstructured":"30) Yao, H., et al.: Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis. <i>J Biol Chem<\/i>. <b>283<\/b>: 20060-20068, 2008."},{"key":"31","unstructured":"31) Nakashima, K., et al.: PAD4 regulates proliferation of multipotent haematopoietic cells by controlling c-myc expression. <i>Nat Commun<\/i>. <b>4<\/b>: 1836, 2013."},{"key":"32","unstructured":"32) Christophorou, M.A., et al.: Citrullination regulates pluripotency and histone H1 binding to chromatin. <i>Nature<\/i>. <b>507<\/b>: 104-108, 2014."},{"key":"33","unstructured":"33) Brinkmann, V., et al.: Neutrophil extracellular traps kill bacteria. <i>Science<\/i>. <b>303<\/b>: 1532-1535, 2004."},{"key":"34","unstructured":"34) Li, P., et al.: PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. <i>J Exp Med<\/i>. <b>207<\/b>: 1853-1862, 2010."},{"key":"35","unstructured":"35) Marichal, T., et al.: DNA released from dying host cells mediates aluminum adjuvant activity. <i>Nat Med<\/i>. <b>17<\/b>: 996-1002, 2011."},{"key":"36","unstructured":"36) Tillack, K., et al.: T lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responses. <i>J Immunol<\/i>. <b>188<\/b>: 3150-3159, 2012."},{"key":"37","unstructured":"37) Sadik, C.D., et al.: Neutrophils orchestrate their own recruitment in murine arthritis through C5aR and FcgammaR signaling. <i>Proc Natl Acad Sci U S A<\/i>. <b>109<\/b>: E3177-3185, 2012."},{"key":"38","unstructured":"38) Rohrbach, A.S., et al.: PAD4 is not essential for disease in the K\/BxN murine autoantibody-mediated model of arthritis. <i>Arthritis Res Ther<\/i>. <b>14<\/b>: R104, 2012."},{"key":"39","unstructured":"39) Willis, V.C., et al.: N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. <i>J Immunol<\/i>. <b>186<\/b>: 4396-4404, 2011."}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/37\/3\/37_154\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T04:54:23Z","timestamp":1621486463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/37\/3\/37_154\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.37.154","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}